Top Story

Canagliflozin-metformin combo drug added benefits unproven, German quality group says

November 24, 2014

The new fixed combination of canagliflozin with metformin to treat type 2 diabetes offers no added benefit over the appropriate comparator therapy, according to a press release from the German Institute for Quality and Efficiency in Health Care.

A dossier assessment for the drug, approved since April 2014 for use in adult patients unable to achieve adequate glycemic control through diet and exercise alone, did not present data for possible subindications, the group argued.

In the Journals

Economic burden of diabetes continues to grow

November 24, 2014
Recent study findings published in Diabetes Care suggest that the economic burden of diabetes in the United States is continuing to rise. “These statistics…
In the Journals

HbA1c, diabetic retinopathy relationship supports cut-point diagnosis in Asians

November 24, 2014
The use of HbA1c levels to diagnose diabetes is appropriate among Asian populations, according to research published in The Journal of Clinical Endocrinology &

Houston first US city to join Cities Changing Diabetes program

November 23, 2014
A partnership was recently announced between the city of Houston and Novo Nordisk to fight the urban diabetes epidemic, according to a company press release. The Cities…
CME
Improving Outcomes

Improving Outcomes with SGLT2 Cotransporter Inhibitors in Challenging T2DM Patients: Updates from EASD 2013

This activity is supported by an educational grant from Janssen Pharmaceuticals.

Recent advances with novel orally administered SGLT2 cotransporter inhibitors, a new class of antidiabetes agents that…
More »
Meeting News Coverage Video
thumbnail for video 3857626096001

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed…
More »
CME
Dialogues in Diabetes

Dialogues in Diabetes: Volume 3, Number 4

Recent advances in incretin-based therapies have targeted reducing cardiovascular risk in patients with type 2 diabetes…
More »

Canagliflozin-metformin combo drug added benefits unproven, German quality group says

November 24, 2014
The new fixed combination of canagliflozin with metformin to treat type 2 diabetes offers no added benefit over the appropriate comparator therapy…
In the Journals

Economic burden of diabetes continues to grow

November 24, 2014
Recent study findings published in Diabetes Care suggest that the economic burden of diabetes in the United States is continuing to rise…
In the Journals

HbA1c, diabetic retinopathy relationship supports cut-point diagnosis in Asians

November 24, 2014
The use of HbA1c levels to diagnose diabetes is appropriate among Asian populations, according to research published in The Journal of Clinical

Houston first US city to join Cities Changing Diabetes program

November 23, 2014
A partnership was recently announced between the city of Houston and Novo Nordisk to fight the urban diabetes epidemic, according to a company press…
In the Journals

Lung transplant increased risk for dysglycemia, new-onset diabetes

November 21, 2014
In the first year after undergoing a lung transplant, most patients experience dysglycemia and may also be at significant risk for new-onset…
In the Journals

Mobile telehealth program helped shift behavior in patients with diabetes

November 21, 2014
Behaviorally driven telephone health interventions can be used to address several pathways associated with sustained lifestyle change in patients…
Lauren Sparks In the JournalsPerspective

Exercise response, epigenetic profiles key in improving type 2 diabetes interventions

November 21, 2014
Investigating exercise resistance mechanisms would lead to better understanding of how training efforts relate to type 2 diabetes and potentially…
Marcus Lind In the JournalsPerspective

Patients with type 1 diabetes at increased risk for all-cause, CVD mortality

November 20, 2014
The likelihood of dying from any cause or cardiovascular causes is two times higher in patients with type 1 diabetes and an HbA1c level ≤6.9%…
Rita Kalyani In the Journals

High HbA1c linked to low muscle strength

November 18, 2014
Hyperglycemia predicted persistently lower muscle strength in patients as they age, but peripheral neuropathy may partly account for the effects…
Joseph Muhlestein, MD Meeting News CoveragePerspective

FACTOR-64: CCTA screening for CAD failed to reduce 4-year events in diabetes patients

November 17, 2014
CHICAGO — Screening for CAD by coronary computed tomography angiography did not reduce the composite rate of all-cause mortality, nonfatal MI…
More Headlines »
morganatic-roan
morganatic-roan